ISRCTN15121868已完成未知
Study for rhabdomyosarcoma and other malignant soft tissue tumours of childhood
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
2010 results in https://www.ncbi.nlm.nih.gov/pubmed/20338746 (added 21/01/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Soft tissue sarcoma at one of the following sites: Vagina - Uterus - Paratestis - Orbit - Head and Neck - Bladder - Prostate - Limbs
- •2. Histological types: Rhabdomyosarcoma - Embryonal sarcoma - Undifferentiated sarcoma - Extra osseous Ewing's sarcoma - Soft tissue primitive neuroectodermal tumours
- •3. Stages I and II
- •4. Aged 6 months to 18 years
- •5. Less than 8 weeks since diagnostic biopsy
排除标准
- •Does not match inclusion criteria
研究者
相似试验
招募中
3 期
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaEmbryonal RhabdomyosarcomaFusion-Negative Alveolar RhabdomyosarcomaSpindle Cell/Sclerosing RhabdomyosarcomaNCT05304585Children's Oncology Group205
终止
3 期
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of ChildhoodMalignant Soft TissueRhabdomyosarcomaNCT00162695Gustave Roussy, Cancer Campus, Grand Paris400
进行中（未招募）
不适用
Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old PatientsRhabdomyosarcomaNCT03462888Centre Oscar Lambret113
终止
1 期
Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid SarcomaAdvanced Soft-tissue SarcomaAdvanced Epithelioid SarcomaNCT04204941Epizyme, Inc.25
已完成
不适用
Italian Sarcoma Group: non-metastatic OsteoSarcoma 1OsteosarcomaBone cancerCancerISRCTN21335128Orthopaedic Institute Rizzoli (Istituti Ortopedici Rizzoli) (Italy)246